CN1925863A - 用于治疗sars的黄芩属提取物 - Google Patents

用于治疗sars的黄芩属提取物 Download PDF

Info

Publication number
CN1925863A
CN1925863A CNA2005800060853A CN200580006085A CN1925863A CN 1925863 A CN1925863 A CN 1925863A CN A2005800060853 A CNA2005800060853 A CN A2005800060853A CN 200580006085 A CN200580006085 A CN 200580006085A CN 1925863 A CN1925863 A CN 1925863A
Authority
CN
China
Prior art keywords
purposes
plant
scutellaria
species
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800060853A
Other languages
English (en)
Chinese (zh)
Inventor
钟守明
余虹雯
罗伯特·弥勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phynova Ltd
Original Assignee
Phynova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phynova Ltd filed Critical Phynova Ltd
Publication of CN1925863A publication Critical patent/CN1925863A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
CNA2005800060853A 2004-02-27 2005-02-25 用于治疗sars的黄芩属提取物 Pending CN1925863A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0404327.9 2004-02-27
GB0404327A GB2411354B (en) 2004-02-27 2004-02-27 Use of Scutellaria for the treatment of viral infections

Publications (1)

Publication Number Publication Date
CN1925863A true CN1925863A (zh) 2007-03-07

Family

ID=32050939

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800060853A Pending CN1925863A (zh) 2004-02-27 2005-02-25 用于治疗sars的黄芩属提取物

Country Status (7)

Country Link
US (1) US20080038382A1 (enExample)
EP (1) EP1734976A1 (enExample)
JP (1) JP2007524709A (enExample)
CN (1) CN1925863A (enExample)
AU (1) AU2005216697A1 (enExample)
GB (2) GB2411354B (enExample)
WO (1) WO2005082388A1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101701245B (zh) * 2009-10-21 2013-06-19 中国科学院生物物理研究所 从中药中筛选sars冠状病毒主蛋白酶抑制剂的方法
CN113209164A (zh) * 2020-02-06 2021-08-06 中国科学院上海药物研究所 黄芩、连翘、金银花主要成分及其组合物在抗冠状病毒中的应用
CN113244211A (zh) * 2020-02-07 2021-08-13 中国科学院上海药物研究所 黄芩主要成分黄芩素、黄芩苷及其组合物在抗冠状病毒中的应用
CN113244212A (zh) * 2020-02-10 2021-08-13 中国医学科学院药物研究所 黄芩素在制备预防和/或治疗新型冠状病毒感染疾病的药物中的应用
WO2021179878A1 (zh) * 2020-03-09 2021-09-16 大连富生天然药物开发有限公司 靶向3CLpro的连翘苷及其衍生物和抗新冠应用
CN113813271A (zh) * 2020-11-09 2021-12-21 首都医科大学 连翘酯苷f在制备抗冠状病毒产品中的应用
RU2804307C1 (ru) * 2020-03-09 2023-09-27 Далянь Фушэн Нэчурал Медсин Дивелопмент Ко., Лтд. Филлирин и его производные для подавления белка 3clpro и борьбы с вирусом covid-19

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006100710A1 (ja) * 2005-03-18 2008-08-28 太陽化学株式会社 重症急性呼吸器症候群の予防および治療用組成物
CN103720650A (zh) * 2014-01-17 2014-04-16 中国药科大学 一种具有抗流感病毒作用的黄芩苷注射剂
CN104800318A (zh) * 2014-01-26 2015-07-29 天津嘉创生物科技有限公司 治疗畜禽上呼吸道感染的中药组合物及其制备方法
CN105372377B (zh) * 2014-08-07 2017-09-29 富力 一种原料药连翘苷的质量检测方法
CN104356185B (zh) * 2014-09-26 2017-05-17 山西大学 一种提取黄芩苷的方法
CN105168807B (zh) * 2015-10-16 2019-04-19 大连民族大学 治疗猪蓝耳病的中药组合物及其制备方法
WO2021188614A1 (en) * 2020-03-18 2021-09-23 Dejia Harmony Llc Composition, methods of making and using for treating a viral infection, including coronavirus infection
AU2021281159B2 (en) * 2020-05-29 2024-09-19 Vedicinals India Private Limited A composition for management of COVID-19 and associated disorders
RU2741714C1 (ru) * 2020-08-13 2021-01-28 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Ингибитор репликации коронавируса SARS-CoV-2 на основе водного экстракта гриба Inonotus obliquus
US20220054575A1 (en) * 2020-08-19 2022-02-24 Natreon, Inc. Protection against coronavirus infection by extracts and extract components
RU2747018C1 (ru) * 2020-10-14 2021-04-23 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере зашиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Ингибитор репликации коронавируса SARS-CoV-2 на основе меланина из гриба Inonotus obliquus
RU2752872C1 (ru) * 2020-11-03 2021-08-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Ингибитор репликации коронавируса SARS-CoV-2 на основе гуминовых веществ
CN118477064B (zh) * 2024-05-14 2024-12-20 南阳师范学院 黄芩素在抗大口黑鲈弹状病毒方面的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
US6083921A (en) * 1998-01-12 2000-07-04 Xu; Kai Jian Pharmaceutical compositions and method of using same
CN1309399C (zh) * 2000-10-25 2007-04-11 国家中药制药工程技术研究中心 复方双黄连制剂及制备方法
CN1470262A (zh) * 2002-07-23 2004-01-28 北京大学安康药物研究院 一种双黄连制剂及其制备方法
CN1449813A (zh) * 2003-04-29 2003-10-22 兰金初 治疗非典型肺炎的药物
CN1159060C (zh) * 2003-05-06 2004-07-28 哈药集团中药二厂 注射用双黄连在制备用于治疗严重急性呼吸道综合症的药物中的应用
CN1454665A (zh) * 2003-06-02 2003-11-12 丁润泉 一种防治sars病毒的中药
CN1164267C (zh) * 2003-06-02 2004-09-01 中国科学院上海药物研究所 绿原酸的医学用途及它的制剂
CN1238037C (zh) * 2003-06-09 2006-01-25 方文理 治疗肺炎和非典型肺炎的药物
CN1135111C (zh) * 2003-06-13 2004-01-21 胡馨元 抗非典型性肺炎汤
CN1476886A (zh) * 2003-07-01 2004-02-25 陈淀炜 抗癌抗sars保健茶

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101701245B (zh) * 2009-10-21 2013-06-19 中国科学院生物物理研究所 从中药中筛选sars冠状病毒主蛋白酶抑制剂的方法
CN113209164A (zh) * 2020-02-06 2021-08-06 中国科学院上海药物研究所 黄芩、连翘、金银花主要成分及其组合物在抗冠状病毒中的应用
CN113209164B (zh) * 2020-02-06 2023-01-20 中国科学院上海药物研究所 黄芩、连翘、金银花主要成分及其组合物在抗冠状病毒中的应用
CN113244211A (zh) * 2020-02-07 2021-08-13 中国科学院上海药物研究所 黄芩主要成分黄芩素、黄芩苷及其组合物在抗冠状病毒中的应用
CN113244212A (zh) * 2020-02-10 2021-08-13 中国医学科学院药物研究所 黄芩素在制备预防和/或治疗新型冠状病毒感染疾病的药物中的应用
WO2021179878A1 (zh) * 2020-03-09 2021-09-16 大连富生天然药物开发有限公司 靶向3CLpro的连翘苷及其衍生物和抗新冠应用
RU2804307C1 (ru) * 2020-03-09 2023-09-27 Далянь Фушэн Нэчурал Медсин Дивелопмент Ко., Лтд. Филлирин и его производные для подавления белка 3clpro и борьбы с вирусом covid-19
CN113813271A (zh) * 2020-11-09 2021-12-21 首都医科大学 连翘酯苷f在制备抗冠状病毒产品中的应用
CN113813271B (zh) * 2020-11-09 2023-12-12 首都医科大学 连翘酯苷f在制备抗冠状病毒产品中的应用

Also Published As

Publication number Publication date
WO2005082388A1 (en) 2005-09-09
AU2005216697A1 (en) 2005-09-09
US20080038382A1 (en) 2008-02-14
GB0404327D0 (en) 2004-03-31
EP1734976A1 (en) 2006-12-27
GB2411354A (en) 2005-08-31
JP2007524709A (ja) 2007-08-30
GB2425476A (en) 2006-11-01
GB0608398D0 (en) 2006-06-07
GB2411354B (en) 2008-02-20

Similar Documents

Publication Publication Date Title
CN111888435B (zh) 一种抗冠状病毒的中药组合物及其在治疗炎症中的用途
US20080038382A1 (en) Extracts of Scutellaria for the Treatment of Sars
CN1925864A (zh) 治疗丙型肝炎的基于植物的药物
CN111870657B (zh) 一种中药组合物在制备治疗或预防冠状病毒感染的药物中的应用
CN1622817A (zh) 用于皮炎治疗的饮用茶
CN1729812A (zh) 青稞保健茶及其制备方法
KR20210116929A (ko) 숙취해소제의 제조 방법 및 이에 의해 제조된 숙취해소제
TR201802779T4 (tr) Bitkisel formülasyonlar.
CN113499381B (zh) 中药组合物和/或包含该中药组合物的药物制剂在抗流感病毒中的应用
CN1840166A (zh) 温胆汤现代中药口服制剂及其生产方法
CN1724040A (zh) 治疗小儿感冒及反复感冒的中成药及其制备方法
CN1785371A (zh) 一种小儿退热的中药制剂及其制备方法
CN1119107A (zh) 一种治疗呼吸系统疾病特别是哮喘病的药品及其制备方法
JP2021061828A (ja) ２種以上の生薬抽出物を有効成分として含む免疫力増進用組成物
CN1772079A (zh) 一种治疗上呼吸道感染的药物及其制备方法
CN1254266C (zh) 感冒胶囊及其制备方法
CN1076616C (zh) 一种纯天然除烟害保健品
CN101062314A (zh) 一种治疗痛风的药物及其制备方法
CN1589892A (zh) 一种治疗急、慢性咽炎的药物组合物及其制备方法
CN113101331A (zh) 一种百里香药茶及其制备方法和应用
GB2425477A (en) Extract of Scutellaria for the treatment of RSV
KR102738005B1 (ko) 면역증진 또는 항바이러스용 조성물
CN1745788A (zh) 一种治疗小儿腹泻的中药制剂及制备方法
CN1660249A (zh) 一种四季三黄新制剂和制备方法及用途
KR102577328B1 (ko) 생약 추출물 2종 이상을 유효성분으로 포함하는 면역력 증진용 조성물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication